Potential role of Candida albicans germ tube antibody in the diagnosis of deep-seated candidemia

Medical Mycology

Volumn 52, Issue 3, 2014, Pages 270-275

  Martínez Jiménez, M Carmen ^a,b   Muñoz, Patricia ^a,b,c,d   Guinea, Jesús ^a,b,c,d   Valerio, Maricela ^a,b   Alonso, Roberto ^a,b   Escribano, Pilar ^a,b,c   Bouza, Emilio ^a,b,c,d  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Candida albicans germ tube specific antibody (CAGTA); candidemia; Deep seated candidiasis

Indexed keywords

CANDIDA ALBICANS GERM TUBE SPECIFIC ANTIBODY; FUNGUS ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ADULT DISEASE; AGED; ARTICLE; BLOOD SAMPLING; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CANDIDEMIA; CATHETER INFECTION; CHORIORETINITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DEEP SEATED CANDIDIASIS; DIAGNOSTIC TEST ACCURACY STUDY; ENDOCARDITIS; FEMALE; FUNGAL DETECTION; GASTROINTESTINAL DISEASE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOASSAY; IMMUNOFLUORESCENCE TEST; INDWELLING URINARY CATHETER; INTRAVASCULAR CATHETER; INVASIVE CANDIDIASIS; MALE; NON DEEP SEATED CANDIDIASIS.; PREDICTIVE VALUE; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SOLID TUMOR; TOTAL PARENTERAL NUTRITION; UROSEPSIS;

CANDIDA ALBICANS GERM TUBE-SPECIFIC ANTIBODY (CAGTA); CANDIDEMIA; DEEP-SEATED CANDIDIASIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, FUNGAL; CANDIDA; CANDIDEMIA; DIAGNOSTIC TESTS, ROUTINE; FEMALE; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; SPAIN;

CANDIDA ALBICANS;

EID: 84898915053     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1093/mmy/myt025     Document Type: Article

References (20)

1. Clancy CJ, Nguyen MH. Finding the ?missing 50%? of invasive candidiasis: How nonculture diagnostics will improve understanding of disease spectrum and transform patient care. Clin Infect Dis 2013; 56: 1284-1292.
2. Nguyen MH, WisselMC, Shields RK et al. Performance of Candida real-time polymerase chain reaction, beta-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis. Clin Infect Dis 2012; 54: 1240-1248.
3. Moragues MD, Ortiz N, Iruretagoyena JR et al. Evaluation of a new commercial test (Candida albicans IFA IgG) for the serodiagnosis of invasive candidiasis. Enferm Infecc Microbiol Clin 2004; 22: 83-88 [in Spanish].
4. Linares MJ, Javier MR, Villanueva JL et al. Detection of antibodies to Candida albicans germ tubes in heroin addicts with systemic candidiasis. Clin Microbiol Infect 2001; 7: 218-226.
5. Garc?a-Ruiz JC, Arilla MC, Reg ? ulez P et al. Detection of antibodies to Candida albicans germ tubes for diagnosis and therapeutic monitoring of invasive candidiasis in patients with hematologic malignancies. J Clin Microbiol 1997; 35: 3284-3287.
6. Pem?an J, Zaragoza R, Quind? os G et al. Clinical factors associated with a Candida albicans germ tube antibody positive test in intensive care unit patients. BMC Infect Dis 2011; 11: 60.
7. La?in A, Elguezabal N, Brena S et al. Diagnosis of invasive candidiasis by enzyme-linked immunosorbent assay using the Nterminal fragment of Candida albicans hyphal wall protein BMC Microbiol 2007; 7: 35.
8. Brand A. Hyphal growth in human fungal pathogens and its role in virulence. Int J Microbiol 2012; 2012: 517-529.
9. Mayer FL, Wilson D, Hube B. Candida albicans pathogenicity mechanisms. Virulence 2013; 4: 119-128.
10. Saville SP, Lazzell AL, Monteagudo C, Lopez-Ribot JL. Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection. Eukaryot Cell 2003; 2: 1053-1060.
11. Cuenca-Estrella M. Laboratory diagnosis of fungal infection diseases. Enferm Infecc Microbiol Clin 2012; 30: 257-264 [in Spanish].
12. Leroy O, Gangneux JP, Montravers P et al. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: A multicenter, prospective, observational study in France (2005-2006). Crit Care Med 2009; 37: 1612-1618.
13. Girmenia C, Martino P, De Bernardis F, Cassone A. Assessment of detection of Candida mannoproteinemia as a method to differentiate central venous catheter-related candidemia from invasive disease. J Clin Microbiol 1997; 35: 903-906.
14. Ponton J, Jones JM. Analysis of cell wall extracts of Candida albicans by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Western blot techniques. Infect Immun 1986; 53: 565-572.
15. Heintz-Buschart A, Eickhoff H, Hohn E, Bilitewski U. Identification of inhibitors of yeast-to-hyphae transition in Candida albicans by a reporter screening assay. J Biotechnol 2013; 164: 137-142.
16. Ponton J, del Palacio A. Advances and limitations in the early diagnosis of invasive yeast infections. Rev Iberoam Micol 2007; 24: 181-186 [in Spanish].
17. Ponton J, Quindos G, Arilla MC,Mackenzie DW. Simplified adsorption method for detection of antibodies to Candida albicans germ tubes. J Clin Microbiol 1994; 32: 217-219.
18. Brunke S, Hube H. Two unlike cousins: Candida albicans and C. glabrata infection strategies. Cell Microbiol 2013; 15: 701-708.
19. Zaragoza R, Pem?an J, Quind? os G et al. Kinetic patterns of Candida albicans germ tube antibody in critically ill patients: Influence on mortality. Clin Vaccine Immunol 2009; 16: 1527-1528.
20. Peman J, Zaragoza R. Towards an early diagnosis of invasive candidiasis in the critically ill patient. Rev Iberoam Micol 2012; 29: 71-75.